Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Saudi Med ; 12(2): 140-51, 1992 Mar.
Article in English | MEDLINE | ID: mdl-17589143

ABSTRACT

A retrospective and prospective study of 1,000 ambulatory and hospitalized diabetic patients was done in Riyadh, Saudi Arabia. Saudis completed 777 (77.7%) and non-Saudis 223 (22.3%). Sex distribution was equal among Saudis, males 389 (50.1%) and females 388 (49.9%), but non-Saudi males were predominant at 153 (68.6%), non-Saudi females 70 (31.4%) reflecting the preponderant male expatriate labor force. A proportion of different types of diabetes was: IDDM 115 (11.7%), non-obese non-insulin dependent diabetes mellitus (NIDDM) 405 (41.0%), obese NIDDM 412 (42.1%), and early onset non-insulin dependent diabetes (diagnosis under 30 years of age), 43 (4.4%). Regarding treatment, 388 (40.6%) received insulin followed by sulfonylurea, alone in 330 (33.5%), diet only 117 (12.0%), combination sulfonylurea and biguanide in 113 (11.6%), biguanide alone in 13 (1.3%) and insulin plus tablets in 7 (0.8%). Of 472 and 426 patients, 29.7% and 30.0% had elevated total cholesterol or triglycerides respectively, while 77.2% of 373 patients had elevated glycosylated hemoglobin (HbA1). At least once in 998 patients, diabetic ketoacidosis occurred in 7.6%.

2.
Ann Neurol ; 24(4): 582-4, 1988 Oct.
Article in English | MEDLINE | ID: mdl-3239959

ABSTRACT

Absence status epilepticus following metrizamide myelography was associated with computed tomographic scan evidence of a high concentration of the dye in brain gray matter. We suggest that absence status epilepticus is due to the direct effect of metrizamide on the cortex and that this clinically treatable condition may have escaped diagnosis in previous reports.


Subject(s)
Brain/diagnostic imaging , Metrizamide/adverse effects , Myelography/adverse effects , Status Epilepticus/chemically induced , Tomography, X-Ray Computed , Adult , Brain/metabolism , Brain/physiopathology , Electroencephalography , Humans , Male , Metrizamide/pharmacokinetics , Status Epilepticus/diagnostic imaging , Status Epilepticus/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...